Alumkal, Joshi
| Bagby, Grover C.
| Bascom, Paul
| Beer, Tomasz M.
| Blanke, Charles D.
| Chui, Stephen
| Deininger, Michael WN
| DeLoughery, Thomas
| Druker, Brian J.
| Epner, Elliot
| Fleming, William H.
| Fromme, Erik
| Greenberg, Daniel
| Hayes-Lattin, Brandon
| Heinrich, Michael C.
| Kemmer, Kathleen
| Kovacsovics, Tibor
| Lopez, Charles D.
| Luoh, Shiuh-Wen
| Mauro, Michael J.
| Maziarz, Richard
| Meyers, Gabrielle
| Okada, Craig
| Ryan, Christopher W.
| Sanborn, Rachel E
| Skach, William
| Streeter, Philip
| Sullivan, Richard
| Thomas, Charles
| | Webster, Devon | |
|
|
|
 |
|
|
Our FacultyRachel E Sanborn, MD
Assistant Professor of Medicine
Specialty: Thoracic Oncology, Medical Oncology and Lung Cancer
Clinic Phone: 503-494-6594
Office Phone: 503-494-8534
E-mail: sanbornr@ohsu.edu
Our goal is to offer a comprehensive multidisciplinary approach to the treatment of patients with thoracic malignancies, with an emphasis on clinical trials as a way of offering the most advanced care and making advances to benefit all patients with thoracic malignancies.
Appointments
- Assistant Professor, Department of Medicine
- Hematology and Medical Oncology
|
|
Professional Education and Training
- Oregon Health & Science University, Portland OR
Fellowship, Hematology and Medical Oncology, July 2002 - June 2005
- University of Illinois at Chicago, Chicago IL
Residency Program, Internal Medicine, July 1999 - June 2002
- Oregon Health & Science University Medical School, Portland, OR
September 1995 - June 1999
M.D. - Cornell College, Mt. Vernon IA, September 1991 - June 1995, Bachelor of Arts in Biology
|
Committee/Organizations
- American Society of Clinical Oncology, Associate Member
- American Society of Hematology, Associate Member
- International Association for the Study of Lung Cancer, Member
- Southwest Oncology Group, Member
- Women Against Lung Cancer, Member
|  |
Certifications
- Board Certified, Internal Medicine
- Board Eligible, Hematology (Pending)
- Board Eligible, Medical Oncology (Pending)
|
Selected Publications
- Sanborn RE, Gonzalez A, Sandler AB. Primary Sarcomas of the Lung. For Raghavan D, Brecher ML, Johnson DH, Meropol NJ, Moots PL, Thigpen JT (eds). Textbook of Uncommon Cancer, third edition. Chichester: Wiley (In final preparation)
- Sanborn R, Sandler AB. Safety of Bevacizumab.Expert Opinion on Drug Safety (In Press)
- Sanborn R, Sandler AB. Duration of Therapy for Non-Small Cell Lung Cancer: A Few Answers, More Questions. Cancer Research (In Press)
- Sanborn R, Blanke CD. Gastrointestinal Stromal Tumors and the Evolution of Targeted Therapy. Clinical Advances in Hematology and Oncology(In Press)
- Sanborn R, Blanke CD. COX-2 Inhibition in Colorectal Cancer: Boom or Bust? Seminars in Oncology 2005; 32: 69-75
- Devine SM, Sanborn R, et al. Fludarabine and Melphalan-Based Conditioning for Patients with Advanced Hematological Malignancies Relapsing After a Previous Hematopoietic Stem Cell Transplant. Bone Marrow Transplantation 2001; 28: 557-562
|
|
